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3Summary
There is a wide recognition that all pharmacists and 
pharmacy technicians, like other health professionals, 
are working under extreme pressures during the 
current pandemic. These are likely to get worse before 
they get better and may recur. Staff are already 
having to make prioritisation decisions and are 
planning for previously unseen situations.
Pharmacists and pharmacy technicians are often 
by their very nature perfectionists and strive to do 
their best. When we find ourselves in situations such 
as these, perfectionism is counterproductive. We 
recognise that safe and effective care – rather than 
ideal care – may be the best and right kind of care 
to provide, in the context of the COVID-19 challenge. 
Pharmacists and pharmacy technicians will need 
to make quicker, timelier decisions which may feel 
uncomfortable, have increased belief in their own 
experience, and draw upon experience around 
them. The guidance in this document is intended for 
utilisation by all sectors of the profession and by staff 
in both strategic roles and those in roles closer to 
patients.
D E C I S I O N S  W E  M A K E  S H O U L D  B E :
• based on the best evidence available at the time
• reasonable and proportionate in the circumstances
• made in accordance with the latest government, 
NHS, regulatory and professional guidance and 
should take account of employers’ guidance
• made as collaboratively as possible, remembering 
that every decision made will impact on others, 
both patients and professionals
• designed to secure safe and effective patient care 
as far as practicable
• timely, recognising that pressure of time 
means that rather than striving for perfection, 
decisions may have to be “good enough for the 
circumstances”
• recorded, including the reasons why decisions were 
made to ensure accountability and understanding 
of prevailing circumstances at the time
In line with the principles above, any judgements on 
decisions and conduct during this pandemic will be 
based on all the prevailing circumstances at the time 
of the decisions and conduct, not with the benefit of 
hindsight. This is supported by the joint statement from 
the health and care professional regulatory bodies. 1
The latest guidance on issues relating to the COVID-19 
pandemic can be found at https://www.rpharms.com/
coronavirus/ and https://www.psni.org.uk/publications/
covid19-regulatory-statements-and-information/
1 https://www.pharmacyregulation.org/news/regulatory-approach-
challenging-circumstances-gphc-and-psni-joint-statement 
accessed 1 April 2020
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Introduction and 
Background
This document has been produced by a short life 
working group convened by the Royal Pharmaceutical 
Society (RPS) to provide guidance to pharmacists 
and registered pharmacy technicians to assist with 
difficult decisions being made in the exceptional 
circumstances presented by COVID-19. It contains 
some guidance on structured decision making and 
some more specific examples relevant to the current 
pandemic. The role pharmacy technician as described 
in this guidance document reflects those that hold a 
professional registration.
COVID-19 brings with it a pandemic of scale not seen 
in our lifetime in the UK. The NHS is already under 
significant pressure and the mortality and morbidity 
statistics are at the time of writing, rising at an 
alarming rate on a daily basis. 
Currently there is no specific national ethical guidance 
relating to pharmacy. As the pandemic progresses, 
our knowledge and wisdom will change before this 
document is updated; bear this in mind when using it 
to support your decision making.
The RPS is an advocate for the profession and strongly 
supports the interests of pharmacists and the public. 
Principles in this document are intended to apply to 
everyone providing pharmacy services recognising 
the importance of the whole pharmacy team working 
as one.
The latest guidance on issues relating to 
the COVID-19 pandemic can be found at 
https://www.rpharms.com/coronavirus / 
and https://www.psni.org.uk/publications/
covid19-regulatory-statements-and-information/ 
The purpose of this guidance is to provide support 
to pharmacists and pharmacy technicians to make 
decisions in these exceptional circumstances and to 
also provide some reassurance that uncomfortable 
decisions made are sound and defensible.
Professional Decision Making
Professional decisions are informed by the best 
available evidence and grounded in reason. 
Accountability is an important part of the covenant the 
profession holds with the public propagating the trust 
that we are gifted by them. When events or decisions 
do not bring the most desirable outcome pharmacists 
and pharmacy technicians often worry that they 
have done wrong and will be penalised because of a 
less desirable outcome. Under these circumstances 
especially, pharmacists and pharmacy technicians 
should focus on reasoned decision-making, which 
underpins the skills of a health professional.
The Medicines Ethics and Practice Guide2 provides a 
model for decision making (Box 1). Having a systematic 
approach allows professionals to account for the 
decisions they make. In times of crisis, this approach 
is offered as a useful support tool to fall back on. Each 
of the factors listed below may be adapted to take 
account of the prevailing circumstances and the time 
available. The time available for making decisions may 
be significantly shortened because of a wide range 
demands including the needs of all patients in need of 
services, limitations on available resources and other 
pressures on the service.
Decision-making is often improved through 
collaborative discussion where possible and 
time allows. During this pandemic, pharmacists 
and pharmacy technicians in all areas may be 
experiencing similar issues and discussion often 
assists. 
Pharmacists and pharmacy technicians should 
be reassured that should decisions be called into 
question at a later date, they will be judged according 
to the circumstances at the time of the decision, not 
with the benefit of hindsight.3
2  Royal Pharmaceutical Society (2019), Medicines, Ethics and 
Practice Guide Edition 43 available from https://www.rpharms.com/
publications/the-mep/mep-viewer-member
3  https://www.pharmacyregulation.org/news/regulatory-approach-
challenging-circumstances-gphc-and-psni-joint-statement 
Accessed 1 April 2020
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1 I D E N T I F Y
Identify the issue/dilemma
2 G AT H E R
Gather relevant information. This will include legal, ethical, 
professional and clinical guidance
3 G E N E R AT E
Consider the range of options in the time available;  
what could I do?
4 C O M PA R E
What are the risks and benefits of each option?
5 D E C I S I O N
Make a reasoned decision based on the evidence gathered
6 R E C O R D
Make a record of both the final decision and the facts that 
informed that decision
7 R E V I E W
As situations change, review the decision in light of 
information, altering practise as necessary and recording 
changes
Box 1. Adapted for emergency circumstances from 
Exercising Professional Judgment RPS Medicines, Ethics 
and Practice Guide4
4  Royal Pharmaceutical Society (2019), Medicines, Ethics and 
Practice Guide Edition 43 available from https://www.rpharms.com/
publications/the-mep/mep-viewer-member
Ethical Framework  
for Decision Making
Every health profession defines its expectations 
through some form of code of ethics, although its 
nomenclature may vary. Pharmacists and pharmacy 
technicians must adhere to the Standards for 
Pharmacy Professionals issued by the regulators, 
the General Pharmaceutical Council5  and the 
Pharmaceutical Society NI. 6
In times such as these, it is critical that individuals work 
flexibly with colleagues across different disciplines and 
sectors, sometimes beyond traditional professional 
boundaries, to ensure the best realistic outcomes 
for patients, taking account of the circumstances 
they are working in. On the public’s behalf, the 
General Pharmaceutical Council (GPhC) and the 
Pharmaceutical Society NI (PSNI) expect pharmacists 
and pharmacy technicians to uphold their respective 
standards, recognising that how this is achieved 
may look very different in the context of the present 
challenge, compared to normal times. The guidance 
that follows is based on two key UK government 
documents. The first was produced in 2007 following 
the SARS outbreak, updated following the H1N1 influenza 
pandemic of 2009 and most recently updated in 
2017.7 The second document was produced by the 
Department of Health and Social Care in March 2020 
to support the wider adult social care arena.8 Using 
these as the basis of this guidance aligns pharmacy 
with not only other medical professionals but also key 
emergency planners supporting health workers.
The UK government influenza guidance detailed that 
there are 8 priority areas to be considered in these 
exceptional times and these are detailed in Box 2. 
In broad principle these reflect a just perspective 
under the philosophy that everyone matters and that 
everyone matters equally.
5  https://www.pharmacyregulation.org/sites/default/files/standards_
for_pharmacy_professionals_may_2017_0.pdf accessed 30 March 
2020
6  https://www.psni.org.uk/psni/about/code-of-ethics-and-
standards/ accessed 6 April 2020
7  https://www.gov.uk/guidance/pandemic-flu#ethical-framework 
accessed 30 March 2020
8  https://www.gov.uk/government/publications/covid-19-ethical-
framework-for-adult-social-care/responding-to-covid-19-the-
ethical-framework-for-adult-social-care#respect Accessed 30 
March 2020
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Equal respect everyone matters and everyone matters equally, but this does not mean that everyone will be treated  the same
Respect keep people as informed as possible; give people the chance to express their views on matters that affect them; respect people’s personal choices about care and treatment
Minimise the harm of 
the pandemic reduce spread, minimise disruption, learn what works
Fairness
everyone matters equally. People with an equal chance of benefiting from a resource should have an 
equal chance of receiving it – although it is not unfair to ask people to wait if they could get the same 
benefit later
Working together we need to support each other, collaborate and work flexibly, take responsibility for our own behaviour and share information appropriately
Reciprocity those who take on increased burdens should be supported in doing so
Keeping things in 
proportion
information communicated must be proportionate to the risks; restrictions on rights must be 
proportionate to the goals
Flexibility plans must be adaptable to changing circumstances
Open and transparent 
decision-making
good decisions will be as inclusive, transparent and reasonable as possible. They should be rational, 
evidence-based, the result of a reasonable process and practical in the circumstances
Box 2. Ethical values adapted from “Pandemic flu planning information for England and the devolved 
administrations, including guidance for organisations and businesses.”9
9  https://www.gov.uk/guidance/pandemic-flu#ethical-framework accessed 30 March 2020
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Guidance relating 
to specific issues
Maintaining patient safety
Pharmacists’ key priorities are to protect patients and 
to make optimal use of medicines. Where resource 
especially human resource, is depleted all tasks should 
be reviewed for immediate necessity and prioritised. 
In a pandemic, it is acceptable to adhere to a patient’s 
confirmed current prescribed therapy, where time 
spent on optimisation might prevent treatment of 
others. Continuity of medication therapy and patient 
safety will be prioritised over medicines optimisation. 
The opposite applies to therapies where stewardship is 
of paramount importance for example (but not limited 
to) use of antibiotics, opioid pain relief and high risk 
medicines. 
Managing staff and workload wisely is key for effective 
pharmacy operations. Pharmacists and pharmacy 
technicians should ensure that work is effectively 
delegated where possible to allow greater oversight 
and support of operations. Workforce management 
should be optimised so that staff are employed at the 
upper end of their professional skills and experience. 
Caution should be exercised when contemplating 
the delegation of tasks, and proper account taken 
of relevant legal requirements designed to secure 
patient safety.
Patient safety incidents are often caused by human 
factors such as lack of rest breaks, poor nutrition and 
dehydration. Systems established to reduce human 
factor-related errors should continue to be employed 
whenever possible. Pharmacists and pharmacy 
technicians should ensure, as far as practicable, that 
breaks both physical and mental are part of workload 
planning and are not overlooked even in difficult times.
Maintaining the safety of staff and 
volunteers
In this pandemic there has already been abuse 
of pharmacy staff, especially in primary care.10 
Pharmacists and pharmacy technicians should 
remember that they are the guardians of the 
nation’s medicines and maintain confidence in their 
own abilities in handling these difficult situations 
professionally and assertively where necessary. 
Person-centred care means understanding 
patient preferences and incorporating them where 
practicable, it does not mean all patient demands 
must be met. When they cannot be met or cannot be 
met as promptly as in normal times, it is important to 
manage patient expectations.
The safety of the workforce is paramount. Without an 
effective healthcare workforce, there is no care. Risk 
assessments should be dynamic and under constant 
review. Where the safety of staff is called into question 
appropriate action should be taken.
Volunteers will become an important part of the 
pandemic response. The role volunteers carry out 
should be clearly defined and agreed with appropriate 
training and supervision as per other staff members. 
Reasonable regard must be had to their safety. 
10  https://www.bbc.co.uk/news/uk-wales-52033913 accessed 4 April 
2020
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Working outside normal areas of 
specialism and/or competence
In normal times, pharmacists and pharmacy 
technicians must recognise and work within the 
limits of their knowledge and skills, and refer to others 
when needed. During a pandemic all sectors will be 
impacted by increased workload with concurrent 
reductions in staffing and skill mix as staff and family 
members become unwell. Pharmacists and pharmacy 
technicians may need to develop competence rapidly 
in areas which are in demand. Early consideration 
should be given to additional upskilling, ensuring 
appropriate recording of training.
The immediate need to ensure that patients receive 
medication or other treatment may involve working 
in unfamiliar areas. It is necessary to balance the 
importance of meeting patients’ immediate needs 
with the requirement to work within one’s competence: 
the goal when working in unfamiliar territory is patient 
safety and wellbeing and ensuring patients will not 
be in unnecessary pain or put at risk if the medication 
or treatment is not provided. As demand outstrips 
supply, the maintenance of key services will be a 
priority. All staff, irrespective of seniority or role, should 
be flexible in order to support priority and depleted 
areas. Appropriate care and due diligence should be 
exercised in redeploying resource. 
Pharmacist prescribers, for example, will be competent 
to prescribe in their own area of practice but should 
feel supported to broaden their prescribing practice 
to other appropriate areas as non-specialists, where 
they can still positively impact on patient safety. In 
situations such as these, pharmacist prescribers can 
provide important support to improve staff skill mix 
and effective management of patient case load and 
complexity. 
Pharmacy Technicians may be deployed into areas to 
provide medicines administration, therefore they must 
ensure that they work as part of the multidisciplinary 
team, recognising their scope of practice and where 
they can safely add value.
Under the current exceptional circumstances, 
it is important that pharmacists and pharmacy 
technicians focus on meeting immediate needs rather 
than striving for perfection.
Allocating scarce supplies of 
medicines and devices
Shortages in the medicine supply chain are not 
uncommon and significantly exacerbated during 
surges of demand. Staff at all levels and in all settings 
may be asked to make difficult and time-pressurised 
decisions around which patients receive which 
medicines, although the form of these decisions 
will vary. In some cases, multidisciplinary decisions 
around treatment withdrawal may need to be taken. 
Critical care staff will be familiar with decisions around 
withdrawal of care; many others will not and will find 
them difficult11 and be caused moral distress (see 
later). Should this be the case it is crucial that patients 
affected continue to receive compassionate care.12 
Decisions should be made using the best evidence 
available at the time and in accordance with 
national and local guidance. All decisions around 
resource allocation will have wider impact. In primary 
care, decisions may have to be made alone in 
circumstances where the prescriber would normally 
have been contacted but is unavailable, or because 
the wellbeing of patients does not allow time for the 
prescriber to be contacted. If time permits and there is 
a head office, or other pharmacist who may be asked 
for a view, this should be considered.
All decisions should be discussed, ideally across the 
multi-professional team in secondary care, to gather 
wider professional guidance and understand the 
potential for unintended consequences and likely 
impact. The Royal College of Anaesthetists and others 
have produced helpful guidance on use of scarce 
intensive care medicines.13
Where decisions are made that would not be  
taken in normal circumstances, a brief record of  
the justifications and prevailing conditions should  
be made.
It is common and acceptable practice to operate 
a “First come, First served” queuing approach, until 
medicines availability becomes critical. At this 
point, pharmacists should use their discretion and 
professional judgement as to the apportionment of 
scarce medication. For example, it may be appropriate 
to apportion available stock amongst current patients 
to allow time for treatment options to be considered 
and potentially adjusted. 
11  Wilkinson, D., and J Savulescu. 2012. A costly separation between 
withdrawing and withholding treatment in intensive care. Bioethics 
26 (1):32-48. doi.org/10.1111/j.1467-8519.2012.01981.x
12  https://www.bma.org.uk/media/2226/bma-covid-19-ethics-
guidance.pdf accessed 2 April 2020
13  https://icmanaesthesiacovid-19.org/drug-demand-supply-
guidance accessed 2 April 2020
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Following of legislative 
requirements
The law is a minimum standard to allow society to 
function. It is designed in such a way that it is read 
as being universally applicable without context. The 
circumstances being witnessed are exceptional. 
So long as a pharmacist is able to account for 
their decisions, some departure from strict legal 
requirements may be the right thing to do, for example 
to reduce the risk of death or reduce intolerable pain. 
Guidance from the GPhC14 highlights that professional 
judgment is acceptable and encouraged; for 
example, in the splitting of 100 tablet original packs of 
paracetamol. Examples where professionals have to 
exercise judgment might include missing prescription 
details, including controlled drug prescriptions, where 
due diligence has been exercised and the professional 
is confident that the prescriber’s wishes are clear. 
Where a prescriber’s wishes are less clear, a reasoned 
decision-making process should be followed, for 
example, a missing dose on a drug chart could be 
established by referring to the patient’s summary care 
record, even if the patient has not consented to this. 
Emergency supply provisions should be used to their 
fullest to facilitate continuity of patient care. 
By contrast, it can never be acceptable for corporate 
or organisational instructions or ‘standard operating 
procedures’ to seek to normalise illegality.
Record keeping
Accountability of professionals is an important part 
of our covenant with the public. To achieve this and to 
protect ourselves, we make records. Record keeping 
may be reduced to the absolute minimum necessary 
to facilitate safe care in these difficult circumstances. 
Pharmacists and pharmacy technicians are advised 
to make notes of all key decisions made including 
the environmental circumstances at the time the 
decisions were made and any key facts. Should a 
complaint be received at a later date, decisions 
relating to conduct will be made in the context of the 
prevailing conditions at the time.15 Such conditions 
might include urgency/time available to make 
decision, needs of other patients, availability of 
medicines, access to prescribers and other specialist 
colleagues, time at work, availability of rest/meal 
breaks, availability of resources, indicative competing 
demands (including personal circumstances), and 
staff to patient ratios.
14  https://www.pharmacyregulation.org/standards/guidance/
questions-and-answers-coronavirus accessed 2 April 2020
15  https://www.pharmacyregulation.org/news/regulatory-approach-
challenging-circumstances-gphc-and-psni-joint-statement 
accessed 1 April 2020 
Direct and indirect discrimination 
in decision making
All patients irrespective of background matter equally. 
However, that does not necessarily mean that all 
will be treated the same. When making decisions, 
particular care should be given to ensuring that 
individuals are not discriminated against especially 
during decisions about treatment options, including 
availability or allocation.  Decisions pertaining to 
protected characteristics that have no evidenced 
implication on likely survival/”capacity to benefit 
quickly” such as age, religious views, disability 
including mental or learning difficulties are likely to 
be unlawful. Decisions where survival/“capacity to 
benefit quickly” is likely to impact on outcomes such as 
patients with severe respiratory failure secondary to 
COVID-19 would be acceptable.
Guidance recently issued by the British Medical 
Association16 states:  “although a ‘capacity to benefit 
quickly’ test would be indirect discrimination, in our 
view it would be lawful in the circumstances of a 
serious pandemic because it would amount to ‘a 
proportionate means of achieving a legitimate aim’, 
under s19 (1) of the Equalities Act – namely fulfilling the 
requirement to use limited NHS resources to their best 
effect.”
When considering sales of medicines and health-
related products, pharmacists and pharmacy 
technicians should not:
• make decisions that reduce access of these 
products to more vulnerable patients compared to 
the wider population
• supply or offer to supply chloroquine or 
hydroxychloroquine without establishing it is sought 
for a treatment for which it is licensed, as it is not 
licensed for the treatment of COVID-19
• sell any product or seek any fee at an inflated 
price that may be seen to be profiteering or taking 
advantage of the pandemic.
16  https://www.bma.org.uk/media/2226/bma-covid-19-ethics-
guidance.pdf accessed 2 April 2020
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Moral Distress
Pharmacists and pharmacy technicians, like other 
professionals, are not immune to the circumstances 
being witnessed in both primary and secondary care. 
This is further intensified by some patients’ individual 
behaviour, often out of character when scared, as has 
already been observed in this crisis. 17
Pharmacists and pharmacy technicians are reminded 
of the importance of taking care of their own wellbeing 
and that of those they manage. They should consider 
Post Traumatic Stress Disorder (PTSD) risk reduction 
using techniques such as mindfulness, debriefing and 
psychological support by discussing their experiences 
with others including colleagues, managers, family 
members, other sources of professional or spiritual 
support. 
It is important to consider how the impact of continued 
high workload, tiredness and emotional state affects 
the quality of decision making. Ensuring that you 
manage your mental wellness, seek support from 
others and therefore manage ‘human factors’ is vital in 
times of high pressure and crisis.
Pharmacists and pharmacy technicians will need to 
be able to live with their decisions made during this 
crisis. Adopting an evidence based, fair, systematic 
approach will be key to maintaining personal pride 
and wellbeing. 
Organisations may wish to consider setting up 
multidisciplinary “Ethical support units” as has been 
done in France.18 These groups of senior professionals 
are available as a rapid response support mechanism 
for frontline staff. These groups can support 
colleagues in both primary and secondary care.
Pharmacist Support can be contacted via its website 
https://pharmacistsupport.org/how-we-can-help/ 
and for Northern Ireland https://www.pfni.org.uk/pass/
who-we-are/. Pharmacy Technicians are encouraged 
to utilise the range of resources available free to 
healthcare workers via their employers
17  https://www.bbc.co.uk/news/uk-wales-52033913 Accessed 2 April 
2020
18  Covid-19: Can France’s ethical support units help doctors make 
challenging decisions? 2020; 369:m1291 doi: https://doi.org/10.1136/
bmj.m1291 Accessed 3 April 2020
Managing patients remotely
Reduced staffing or safety concerns may mean 
that care has to be delivered from a distance in 
certain circumstances. This can be effective, even 
if not meeting perfection, and indeed may provide 
important input that might otherwise not be possible.
Guidance from NHSX details information on 
assumptions that can be made with respect to 
information governance and remote working.19
Procurement and distribution
When there are known shortages of medicines 
and devices there is a potential conflict between 
obtaining stock to meet the needs of regular patients 
and reducing stock available for patients elsewhere. 
To ensure fairness to all patients, pharmacists and 
pharmacy technicians should not stockpile. It is vital 
that knowledge regarding shortages is shared in a 
timely manner with all relevant professionals. This 
allows for better decision making all round, better care 
for patients, especially palliative patients, and can 
reduce stress. 
Stockpiling of medicines in areas not in official supply 
pathways should be strongly discouraged such as 
doctor’s bags, community hubs and care homes as 
such actions are likely to disrupt supply to those who 
need it most.
Pharmacists and pharmacy technicians in both 
primary and secondary care procurement and 
distribution, and in clinical care functions, may 
be faced with supply challenges. This may involve 
consideration of alternative suppliers or sources of 
medicines. Care should be taken to ensure use of 
approved suppliers and quality of medicines offered. 
Normal procedures regarding deliveries and returns 
may need to become more flexible to take into 
account opening times, staff availability and minimise 
wastage.
Consideration of the practicalities of medicines 
supply should be reviewed and consideration given 
to “patient ready” medicines that can be distributed 
under guidance.
19  https://www.nhsx.nhs.uk/key-information-and-tools/information-
governance-guidance/health-care-professionals Accessed 3 April 
2020
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Leadership 
Those in leadership positions should consider 
their additional responsibilities and demonstrate 
professional integrity, taking responsibility for making 
difficult but informed decisions. Organisationally, the 
most appropriate and experienced individuals should 
collaboratively make the key decisions, providing 
direction to more junior staff. 
Those in leadership positions have a responsibility 
to share their experiences and decision making 
processes wherever possible, to increase engagement 
and transparency and to prevent unnecessary 
duplication and wasted time.
Research /Experimental 
treatments 
During this pandemic, research and novel, unlicensed 
treatments may be requested by patients or 
colleagues. Pharmacists should collaborate and 
work in accordance with the latest evidence, putting 
patient safety at the forefront of their decision making.  
Any involvement in research should be in accordance 
with Good Clinical Practice (GCP) and trial protocols, 
ensuring that these have received relevant ethics 
committee approval. Pharmacists should consider 
their role in pharmacovigilance and the benefits this 
may bring to a team.  
General advice is available from the RPS website  
www.rpharms.com/development/
research-and-evaluation. 
Repurposing of medicines
All pharmacists and pharmacy technicians should act 
to ensure the most prudent use of medicines. 
Under no circumstances is it currently acceptable to 
supply patient-returned or date-expired medicines 
without further regulatory advice as this would be in 
contravention of section 64(1) of the Medicines Act 1968 
if a patient is harmed by taking a medicine that is not 
of the nature or quality demanded.20
Should the situation arise that key medicines become 
unavailable, it may be necessary to give consideration 
to the use of some patient returned medication 
(for example from end of life packs) or that which is 
recently expired. Subject to the availability of space 
and segregation from in-date stock, Pharmacists and 
pharmacy technicians should retain patient-returned 
medicines that are likely to be in short supply (taking 
account of the latest COVID-19 infection control 
guidance) as well as recently expired medicines that 
appear of suitable quality for triage and potential 
reuse in case they are needed for future supply should 
in-date stocks be declared exhausted. 
Learning and improvement 
Innovation and adapting to local circumstances 
will create learning and potentially improvement 
opportunities.  It is vital that this learning is shared 
with other professional colleagues. Pharmacists 
and pharmacy technicians should actively seek to 
contribute to organisational and professional forums 
to communicate any learning in a timely manner. This 
may prevent valuable time being exhausted wrestling 
with similar challenges and may provide professional 
networking and support. 
20  http://www.legislation.gov.uk/ukpga/1968/67/section/64 accessed 6 
April 2020
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